A three-judge panel heard arguments on Nov. 17 to decide whether to bring back two class-action lawsuits that allege a link between pregnant women using the drug acetaminophen, and rates of autism and attention-deficit hyperactivity disorder (ADHD) in their children.
The cases stem from hundreds of 2022 lawsuits against Tylenol-acetaminophen producer Johnson & Johnson, which were combined into multi-district litigation in October that year.
A federal judge previously ruled that expert witnesses for the plaintiffs used faulty methodology in coming to their scientific conclusions, and blocked their testimony as inadmissible. However, the Food and Drug Administration (FDA) declared a possible link between the commonly used painkiller and autism in September….